{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T17:27:28Z","timestamp":1794158848159,"version":"4.8.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T00:00:00Z","timestamp":1622419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T00:00:00Z","timestamp":1622419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1038\/s41409-021-01328-4","type":"journal-article","created":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T14:07:02Z","timestamp":1622470022000},"page":"2432-2444","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide"],"prefix":"10.1038","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6062-5980","authenticated-orcid":false,"given":"Albert","family":"Esquirol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jes\u00fas","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariadna","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocio","family":"Parody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4571-5125","authenticated-orcid":false,"given":"Christelle","family":"Ferra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2994-9055","authenticated-orcid":false,"given":"Irene","family":"Garcia Cadenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Herruzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nieves","family":"Dorado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1043-8076","authenticated-orcid":false,"given":"Rafael","family":"Hernani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Sanchez-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Torrent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7966-0356","authenticated-orcid":false,"given":"Jorge","family":"Sierra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5143-4042","authenticated-orcid":false,"given":"Rodrigo","family":"Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Spanish Group for Hematopoietic Stem cell Transplantation (GETH)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,31]]},"reference":[{"key":"1328_CR1","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1200\/JCO.2005.09.117","volume":"23","author":"F Aversa","year":"2005","unstructured":"Aversa F, Terenzi A, Tabilio A, Falzetti F, Carotti A, Ballanti S, et al. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. J Clin Oncol. 2005;23:3447\u201354.","journal-title":"J Clin Oncol"},{"key":"1328_CR2","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.3324\/haematol.2011.059378","volume":"97","author":"B Federmann","year":"2012","unstructured":"Federmann B, Bornhauser M, Meisner C, Kordelas L, Beelen DW, Stuhler G, et al. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3\/CD19 depletion and reduced intensity conditioning: a phase II study. Haematologica. 2012;97:1523\u201331.","journal-title":"Haematologica."},{"key":"1328_CR3","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/sj.bmt.1705445","volume":"38","author":"XJ Huang","year":"2006","unstructured":"Huang XJ, Liu DH, Liu KY, Xu LP, Chen H, Han W, et al. Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies. Bone Marrow Transpl. 2006;38:291\u20137.","journal-title":"Bone Marrow Transpl"},{"key":"1328_CR4","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","volume":"14","author":"L Luznik","year":"2008","unstructured":"Luznik L, O\u2019Donnell P, Symons H, Chen AR, Leffell MS, Zahurak M, et al. HLA haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transpl. 2008;14:641\u201350.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1328_CR5","doi-asserted-by":"publisher","first-page":"1573e1579","DOI":"10.1016\/j.bbmt.2014.05.029","volume":"20","author":"AM Raiola","year":"2014","unstructured":"Raiola AM, Dominietto A, di Grazia C, Lamparelli T, Gualandi F, Ibatici A, et al. Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts. Biol Blood Marrow Transpl. 2014;20:1573e1579.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1328_CR6","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1038\/leu.2015.98","volume":"29","author":"A Ruggeri","year":"2015","unstructured":"Ruggeri A, Labopin M, Sanz G, Piemontese S, Arcese W, Bacigalupo A, et al. Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia. Leukemia 2015;29:1891\u2013900.","journal-title":"Leukemia"},{"key":"1328_CR7","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1182\/blood-2015-04-639831","volume":"126","author":"SO Ciurea","year":"2015","unstructured":"Ciurea SO, Zhang M-J, Bacigalupo AA, Bashey A, Appelbaum FR, Aljitawi OS, et al. Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia. Blood 2015;126:1033\u201340.","journal-title":"Blood"},{"key":"1328_CR8","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1038\/bmt.2017.36","volume":"52","author":"M Kwon","year":"2017","unstructured":"Kwon M, Bautista G, Balsalobre P, Sanchez Ortega I, Montesino P, Bermudez A, et al. Haplo-cord transplantation compared to haploidentical transplantation with post-transplant cyclophosphamide in patients with AML. Bone Marrow Transpl. 2017;52:1138\u201343.","journal-title":"Bone Marrow Transpl"},{"key":"1328_CR9","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/bmt.2014.62","volume":"49","author":"A Bashey","year":"2014","unstructured":"Bashey A, Solomon SR. T-cell replete haploidentical donor transplantation using post-transplant CY: an emerging standard-of-care option for patients who lack an HLA-identical sibling donor. Bone Marrow Transpl. 2014;49:999\u20131008.","journal-title":"Bone Marrow Transpl"},{"key":"1328_CR10","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3324\/haematol.2017.187450","volume":"104","author":"E Brissot","year":"2019","unstructured":"Brissot E, Labopin M, Ehninger G, Stelljes M, Brecht A, Ganser A, et al. Haploidentical versus unrelated allogeneic stem cell transplantation for relapsed\/refractory acute myeloid leukemia: a report on 1578 patients from the Acute Leukemia Working Party of the EBMT. Haematologica 2019;104:524\u201332.","journal-title":"Haematologica"},{"key":"1328_CR11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.bbmt.2015.09.002","volume":"22","author":"A Bashey","year":"2016","unstructured":"Bashey A, Zhang A, Jackson K, Brown S, Ridgeway M, Solh M, et al. Comparison of outcomes of hematopoietic cell transplants from T-replete haploidentical donors using post-transplantation cyclophosphamide with 10 of 10 HLA-A, -B, -C, -DRB1, and -DQB1 allele-matched unrelated donors and HLA-identical sibling donors: a multivariable analysis including disease risk index. Biol Blood Marrow Transpl. 2016;22:125\u201333.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1328_CR12","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s15010-017-1016-1","volume":"45","author":"E Atilla","year":"2017","unstructured":"Atilla E, Atilla PA, Bozda\u011f SC, Demirer T. A review of infectious complications after haploidentical hematopoietic stem cell transplantations. Infection. 2017;45:403\u201311.","journal-title":"Infection."},{"key":"1328_CR13","doi-asserted-by":"publisher","first-page":"S162","DOI":"10.1093\/cid\/ciy658","volume":"67","author":"CH Yan","year":"2018","unstructured":"Yan CH, Wang Y, Mo XD, Sun YQ, Wang FR, Fu H, et al. Incidence, risk factors, microbiology and outcomes of pre-engraftment bloodstream infection after haploidentical hematopoietic stem cell transplantation and comparison with HLA-identical sibling transplantation. Clin Infect Dis. 2018;67:S162\u2013S173.","journal-title":"Clin Infect Dis"},{"key":"1328_CR14","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1093\/cid\/cix690","volume":"65","author":"C Girmenia","year":"2017","unstructured":"Girmenia C, Bertaina A, Piciocchi A, Perruccio K, Algarotti A, Busca A, et al. Incidence, risk factors and outcome of pre-engraftment gram-negative bacteremia after allogeneic and autologous hematopoietic stem cell transplantation: an Italian Prospective Multicenter Survey. Clin Infect Dis. 2017;65:1884\u201396.","journal-title":"Clin Infect Dis"},{"key":"1328_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/tid.12195","volume":"16","author":"A Herbers","year":"2014","unstructured":"Herbers A, Haan A, van der Velden W, Donnelly J, Blijlevens N. Mucositis not neutropenia determines bacteremia among hematopoietic stem cell transplant recipients. Transpl Infect Dis. 2014;16:279\u201385.","journal-title":"Transpl Infect Dis"},{"key":"1328_CR16","doi-asserted-by":"publisher","first-page":"e13217","DOI":"10.1111\/tid.13217","volume":"22","author":"A Modi","year":"2020","unstructured":"Modi A, Rybicki L, Majhail NS, Mossad SB. Severity of acute gastrointestinal graft-vs-host disease is associated with incidence of bloodstream infection after adult allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2020;22:e13217.","journal-title":"Transpl Infect Dis"},{"key":"1328_CR17","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1056\/NEJM199810223391702","volume":"339","author":"F Aversa","year":"1998","unstructured":"Aversa F, Tabilio A, Velardi A, Cunningham I, Terenzi A, Falzetti F, et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N. Engl J Med. 1998;339:1186\u20139.","journal-title":"N. Engl J Med"},{"key":"1328_CR18","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1053\/j.seminoncol.2012.09.005","volume":"39","author":"L Luznik","year":"2012","unstructured":"Luznik L, O\u2019Donnell PV, Fuchs EJ. Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation. Semin Oncol. 2012;39:683\u201393.","journal-title":"Semin Oncol"},{"key":"1328_CR19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/nrclinonc.2015.128","volume":"13","author":"CG Kanakry","year":"2016","unstructured":"Kanakry CG, Fuchs EJ, Luznik L. Modern approaches to HLA haploidentical blood or marrow transplantation. Nat Rev Clin Oncol. 2016;13:10\u201324.","journal-title":"Nat Rev Clin Oncol"},{"key":"1328_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.bbmt.2012.08.014","volume":"19","author":"AM Raiola","year":"2013","unstructured":"Raiola AM, Dominietto A, Ghiso A, Di Grazia C, Lamparelli T, Gualandi F, et al. Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioning. Biol Blood Marrow Transpl. 2013;19:117\u201322.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1328_CR21","first-page":"30089","volume":"S1083-8791","author":"W Arcese","year":"2020","unstructured":"Arcese W, Cerretti R, Sarmati L, Cudillo L, De Angelis G, Mariotti B, et al. Matched-pair analysis of transplant from haploidentical, unmanipulated bone marrow donor versus HLA identical sibling for patients with hematologic malignancies. Biol Blood Marrow Transpl. 2020;S1083-8791:30089\u20136.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1328_CR22","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/ejh.13103","volume":"101","author":"J Gayoso","year":"2018","unstructured":"Gayoso J, Balsalobre P, Kwon M, Herrera P, Berm\u00fadez A, Sampol A, et al. Busulfan based myeloablative conditioning regimens for haploidentical transplantation in high risk acute leukemias and myelodysplastic syndromes. Eur J Haematol. 2018;101:332\u20139.","journal-title":"Eur J Haematol"},{"key":"1328_CR23","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/bmt.2017.111","volume":"52","author":"A Esquirol","year":"2017","unstructured":"Esquirol A, Pascual MJ, Ortiz M, Pi\u00f1ana JL, Ferra C, Garcia Cadenas I, et al. Single-agent GvHD prophylaxis with tacrolimus after post-transplant high-dose cyclophosphamide is a valid option for haploidentical transplantation in adults with hematological malignancies. Bone Marrow Transpl. 2017;52:1273\u20139.","journal-title":"Bone Marrow Transpl"},{"key":"1328_CR24","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.1182\/blood-2014-01-552984","volume":"123","author":"P Armand","year":"2014","unstructured":"Armand P, Kim HT, Logan BR, Wang Z, Alyea EP, Kalaycio ME, et al. Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation. Blood 2014;123:3664\u201371.","journal-title":"Blood"},{"key":"1328_CR25","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s00277-016-2711-1","volume":"95","author":"AJ Ullmann","year":"2016","unstructured":"Ullmann AJ, Schmidt-Hieber M, Bertz H, Heinz WJ, Kiehl M, Kr\u00fcger W, et al. Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016. Ann Hematol. 2016;95:1435\u201355.","journal-title":"Ann Hematol"},{"key":"1328_CR26","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.bbmt.2018.02.021","volume":"24","author":"A Forcina","year":"2018","unstructured":"Forcina A, Lorentino F, Marasco V, Oltolini C, Marcatti M, Greco R, et al. Clinical Impact of Pretransplant Multidrug-Resistant Gram-Negative Colonization in Autologous and Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transpl. 2018;24:1476\u201382.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1328_CR27","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/tid.12365","volume":"17","author":"R Crocchiolo","year":"2015","unstructured":"Crocchiolo R, Bramanti S, Vai A, Sarina B, Mineri R, Casari E, et al. Infections after T-replete haploidentical transplantation and high-dose cyclophosphamide as graft-versus-host disease prophylaxis. Transpl Infect Dis. 2015;17:242\u20139.","journal-title":"Transpl Infect Dis"},{"key":"1328_CR28","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1038\/s41409-019-0475-7","volume":"54","author":"A Fayard","year":"2019","unstructured":"Fayard A, Daguenet E, Blaise D, Chevallier P, Labussi\u00e8re H, Berceanu A, et al. Evaluation of infectious complications after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide following reduced-intensity and myeloablative conditioning: a study on behalf of the francophone society of stem cell transplantation and cellular therapy (SFGM-TC). Bone Marrow Transpl. 2019;54:1586\u201394.","journal-title":"Bone Marrow Transpl"},{"key":"1328_CR29","doi-asserted-by":"publisher","first-page":"e12629","DOI":"10.1111\/tid.12629","volume":"19","author":"M Slade","year":"2017","unstructured":"Slade M, Goldsmith S, Romee R, DiPersio JF, Dubberke ER, Westervelt P, et al. Epidemiology of infections following haploidentical peripheral blood hematopoietic cell transplantation. Transpl Infect Dis. 2017;19:e12629.","journal-title":"Transpl Infect Dis"},{"key":"1328_CR30","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.bbmt.2020.01.013","volume":"26","author":"C Oltolini","year":"2020","unstructured":"Oltolini C, Greco R, Galli L, Clerici D, Lorentino F, Xue E, et al. Infections after allogenic transplant with post-transplant cyclophosphamide: impact of donor HLA-matching. Biol Blood Marrow Transpl. 2020;26:1179\u201388.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"11","key":"1328_CR31","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1093\/cid\/cix646","volume":"65","author":"D Averbuch","year":"2017","unstructured":"Averbuch D, Tridello G, Hoek J, Mikulska M, Akan H, Yanez L, et al. Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group. Clin Infect Dis. 2017;65(11):1819\u201328.","journal-title":"Clin Infect Dis"},{"key":"1328_CR32","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/cncr.31045","volume":"124","author":"S Scheich","year":"2018","unstructured":"Scheich S, Lindner S, Koenig R, Reinheimer C, Wichelhaus TA, Hogardt M, et al. Clinical impact of colonization with multidrug-resistant organisms on outcome after allogeneic stem cell transplantation in patients with acute myeloid leukemia. Cancer 2018;124:286\u201396.","journal-title":"Cancer"},{"key":"1328_CR33","doi-asserted-by":"publisher","first-page":"e465","DOI":"10.3324\/haematol.2016.149880","volume":"101","author":"SR Goldsmith","year":"2016","unstructured":"Goldsmith SR, Slade M, DiPersio JF, Westervelt P, Lawrence SJ, Uy GL, et al. Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide. Haematologica 2016;101:e465\u2013e468.","journal-title":"Haematologica"},{"key":"1328_CR34","doi-asserted-by":"publisher","first-page":"e13096","DOI":"10.1111\/tid.13096","volume":"20","author":"CH Lin","year":"2019","unstructured":"Lin CH, Su YJ, Hsu CY, Wang PN, Teng CJ. Haploidentical allogeneic hematopoietic stem cell transplantation increases the risk of cytomegalovirus infection in adult patients with acute leukemia. Transpl Infect Dis. 2019;20:e13096.","journal-title":"Transpl Infect Dis"},{"key":"1328_CR35","doi-asserted-by":"publisher","first-page":"e13206","DOI":"10.1111\/tid.13206","volume":"22","author":"D Huntley","year":"2020","unstructured":"Huntley D, Gim\u00e9nez E, Pascual MJ, Hern\u00e1ndez-Boluda JC, Gago B, V\u00e1zquez L, et al. Incidence, features, and outcomes of cytomegalovirus DNAemia in unmanipulated haploidentical allogeneic hematopoietic stem cell transplantation with post-transplantation cyclophosphamide. Transpl Infect Dis. 2020;22:e13206.","journal-title":"Transpl Infect Dis"},{"key":"1328_CR36","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/j.bbmt.2014.08.013","volume":"20","author":"A Stasi","year":"2014","unstructured":"Stasi A, Milton DR, Poon LM, Hamdi A, Rondon G, Chen J, et al. Similar transplant outcomes for AML\/MDS patients with haploidentical versus 10\/10 HLA matched unrelated and related donors. Biol Blood Marrow Transpl. 2014;20:1975\u201381.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1328_CR37","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1007\/s00277-015-2423-y","volume":"94","author":"J Tischer","year":"2015","unstructured":"Tischer J, Engel N, Fritsch S, Prevalsek D, Hubmann M, Schulz C, et al. Virus infection in HLA-haploidentical hematopoietic stem cell transplantation: incidence in the context of immune recovery in two different transplantation settings. Ann Hematol. 2015;94:1677\u201388.","journal-title":"Ann Hematol"},{"key":"1328_CR38","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1053\/j.seminhematol.2019.03.005","volume":"56","author":"SR McCurdy","year":"2019","unstructured":"McCurdy SR, Luznik L. Immune reconstitution after T-cell replete HLA-haploidentical transplantation. Semin Hematol. 2019;56:221\u20136.","journal-title":"Semin Hematol"},{"key":"1328_CR39","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.bbmt.2013.11.028","volume":"20","author":"YJ Chang","year":"2014","unstructured":"Chang YJ, Zhao XY, Huang XJ. Immune reconstitution after haploidentical hematopoietic stem cell transplantation. Biol Blood Marrow Transpl. 2014;20:440\u20139.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1328_CR40","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1182\/blood-2015-03-631853","volume":"125","author":"Y Suessmuth","year":"2015","unstructured":"Suessmuth Y, Mukherjee R, Watkins B, Koura DT, Finstermeier K, Desmarais C, et al. CMV reactivation drives post-transplant T cell reconstitution and results in defects in the underlying TCR\u03b2 repertoire. Blood. 2015;125:3835\u201350.","journal-title":"Blood."},{"key":"1328_CR41","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1038\/s41409-020-0865-x","volume":"55","author":"D Huntley","year":"2020","unstructured":"Huntley D, Gim\u00e9nez E, Pascual MJ, Remigia MJ, Amat P, Vazquez L, et al. Reconstitution of cytomegalovirus-specific T-cell immunity following unmanipulated haploidentical allogeneic hematopoietic stem cell transplantation with posttransplant cyclophosphamide. Bone Marrow Transplant. 2020;55:1347\u201356.","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"1328_CR42","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/j.bbmt.2013.07.013","volume":"19","author":"JA Kanakry","year":"2013","unstructured":"Kanakry JA, Kasamon YL, Bola\u00f1os-Meade J, Borrello IM, Brodsky RA, Fuchs E, et al. Absence of posttransplantation lymphoproliferative disorder after allogeneic blood or marrow transplantation using posttransplantation cyclophosphamide as graft-versus-host disease prophylaxis. Biol Blood Marrow Transpl. 2013;19(10):1514\u20137.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1328_CR43","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1038\/bmt.2015.162","volume":"50","author":"LE Lunde","year":"2015","unstructured":"Lunde LE, Dasaraju S, Cao Q, Cohn CS, Reding M, Bejanyan N, et al. Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival. Bone Marrow Transpl. 2015;50:1432\u20137.","journal-title":"Bone Marrow Transpl"},{"key":"1328_CR44","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.bbmt.2018.12.142","volume":"25","author":"OR Copelan","year":"2019","unstructured":"Copelan OR, Sanikommu SR, Trivedi JS, Butler C, Ai J, Ragon BK, et al. Higher incidence of hemorrhagic cystitis following haploidentical related donor transplantation compared with matched related donor transplantation. Biol Blood Marrow Transpl. 2019;25:785\u201390.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"8","key":"1328_CR45","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1016\/j.bbmt.2020.04.028","volume":"26","author":"M Arango","year":"2020","unstructured":"Arango M, Cardona D. Hemorrhagic cystitis after haploidentical transplantation with post-transplant cyclophosphamide: protective effect of MESNA continuous infusion. Biol Blood Marrow Transpl. 2020;26(8):1492\u20136.","journal-title":"Biol Blood Marrow Transpl"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-021-01328-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-021-01328-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-021-01328-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T11:02:34Z","timestamp":1747306954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-021-01328-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,31]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["1328"],"URL":"https:\/\/doi.org\/10.1038\/s41409-021-01328-4","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,31]]},"assertion":[{"value":"22 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Affiliation 1 has been updated with the department details","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}